Sprint Bioscience AB (publ) (SPRINT)

Market
Stockholm
Sector
Healthcare
Trend
Neutral
Last close
3.25 (-1.22% on the day)
MA50
3.56
MA200
2.69
52-week range
0.56–4.49
Market cap
342.9M SEK
P/E
3.28
Dividend yield
0%
Data as of
2026-09-04
Quarterly revenue and earnings, millions of SEK
QuarterRevenueYoY %EarningsYoY %
Q1 202514.1-5.6
Q2 202513.9-7.4
Q3 20255.2-8.4
Q4 2025133.9113.2
Q1 20260-100%-12.9

All markets — KeepWinning global stock screener

Other companies on Stockholm: Ortoma AB (publ) (ORT B), Acrinova AB (publ) (ACRI B), Bio-Works Technologies AB (publ) (BIOWKS), Agtira AB (AGTIRA B), Nexam Chemical Holding AB (publ) (NEXAM), Arctic Minerals AB (publ) (ARCT)